Udaipur,  The second day of the national conference Trends of Transformation in Oncology – Oncoconverge 2026 witnessed detailed deliberations on the changing landscape of cancer treatment, emerging technologies and the need to provide safer, more personalised and compassionate care to patients.

While the first day focused on rapid advances in cancer treatment and emerging medical approaches, discussions on the second day centred on improving the overall treatment journey and quality of life of cancer patients.

Programme Director Dr Manoj Mahajan said the second day began with sessions on oncopathology, with experts discussing the quality of tissue biopsies and their crucial role in accurate cancer diagnosis. Speakers emphasised that timely and precise diagnosis remains the first step in determining the right course of treatment.

The cardio-oncology session focused on the relationship between cancer treatment and cardiovascular health. Experts discussed the importance of identifying and monitoring cardiac risks during cancer therapy, particularly as modern treatments continue to improve survival among patients.

Dr Saurabh Sharma said an important session focused on the diagnosis and management of complex blood cancers such as multiple myeloma. Discussions on challenging cases highlighted the growing shift towards personalised treatment based on the specific needs and clinical profile of each patient.

Dr Ankur Sharma said experts also shared their experiences in managing complex cancers, including MDM glioma, lung cancer and metastatic melanoma. Discussions covered newer drugs, immunotherapy, targeted therapies and emerging technologies in oncology.

A special session on cancer immunotherapy highlighted how treatment approaches that harness the body's own immune system against cancer are opening new avenues of hope for several patients. Experts also discussed the growing role of artificial intelligence and digital technologies in cancer diagnosis and treatment.

Dr Mahajan said, “Breaking the barriers means moving from research to practice and ensuring that scientific advances translate into meaningful benefits for patients.” He stressed the need for collective efforts among doctors, researchers, technology experts and healthcare institutions.

The second day of the conference reinforced the message that although the fight against cancer remains challenging, continuous advances in medical science, technology and personalised care are creating new possibilities and renewed hope for patients and their families.